Positioning no disclosures inside 60 days, left as found
Options put/call open interest 3.64, read 2026-11-05
Ethical passes the values gate
Price285.86 USD
Fair value389.89
Ethical score79.0/100
Value readUndervaluedas of 4 Nov 2026
Our investment reviews on this name
2026-10-21Read Distribution342.08-16.4% to today ✓Accumulation gives way to Distribution after an 11% slide in 7 days
2026-10-14Read Accumulation382.75-25.3% to today Markup gives way to Accumulation after a 6% rise in 12 days
2026-10-02Read Markup362.15-21.1% to today Distribution gives way to Markup after a 9% rise in 2 weeks
2026-09-17Read Distribution333.42-14.3% to today ✓Markup gives way to Distribution first Distribution read since August
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Keysight Technologies holds its Distribution at $285.86. Consolidating, no directional conviction, held for 6 days.
As held on the ledger · 2026-11-04
Phase
Distribution · caution
Quantitative state
Consolidating, no directional conviction, held for 6 days
Price at the screen
$285.86
Valuation
44.63 trailing · 23.67 forward price to earnings
Values screen
PASS· score 79.0
Beta
1.18
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
24.58%
Below 33%
Interest-bearing debt is just 24.6% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
1.87%
Below 33%
Cash held in interest-bearing accounts and securities is 1.9% of assets, under the one-third limit.
Pass
Receivables
24.88%
Below 49%
Money owed to the company is 24.9% of assets, under the 49% limit.
Pass
Revenue purity
1.90%
Below 5%
Only 1.9% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Keysight Technologies clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 25%, inside the ~33% line, and interest is about 2% of its income, under the ~5% line, so it passes.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when KEYS's ethical verdict changes
Today KEYS passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 4 Nov 2026: it trades at roughly a 27% discount to our $389.89 fair value, moderate competitive moat, 36.50% revenue growth.
Fair value range in USD, drawn from the 2026-11-04 screen. The gold marker is the market price at the same screen. A 26.7% discount to the base estimate.
Where our models see it going: fair-value estimate $389.89, with a range of $315.00 to $452.86, dated to the 2026-11-04 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Test gear that quietly powers every gadget
Every time a 5G base station fires up or an electric car rolls off the line, Keysight's boxes sit in the background checking the signals. The firm posts 32% revenue growth, 17% profit margins and an 18% return on equity, all while clearing our ethical screen without a mark.
Yet the shares trade at a forward multiple of 26.6 times earnings against a price already 12% above our fair value. Analyst targets sit higher still, but those numbers bake in continued expansion that looks stretched once growth normalises. Moderate competitive edge offers little cushion if the multiple contracts.
Valuation leaves little room for disappointment in a sector tied to capital spending cycles. Currency swings and slower telecom roll-outs could trim results faster than the multiple suggests. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
KEYS trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-04Distribution$305.11-10.8%Entry 12
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 10.8% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 98%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (13 analysts) rates it buy, with a mean price target of $383.
2026-10-28Distribution$342.08+0.0%Entry 11
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 0% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 98%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (13 analysts) rates it buy, with a mean price target of $383.
The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 10.6% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 7% above its long-term trend line with momentum reading bearish. Over the past year the shares are up 98%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (13 analysts) rates it buy, with a mean price target of $383.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 5.7% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 54% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 98%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (13 analysts) rates it buy, with a mean price target of $383.
2026-10-02Markup · changed$362.15+8.6%Entry 8
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 8.6% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 54% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 98%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (13 analysts) rates it buy, with a mean price target of $383.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.8% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 54% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 98%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (13 analysts) rates it buy, with a mean price target of $383.
2026-08-18Markup$336.02+0.0%Entry 6
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 54% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 98%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (13 analysts) rates it buy, with a mean price target of $383. It reported earnings in this window, a natural checkpoint for the thesis.
2026-08-16Markup · changed$336.02+7.1%Entry 5
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 7.1% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 54% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 98%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (13 analysts) rates it buy, with a mean price target of $383. It reported earnings in this window, a natural checkpoint for the thesis.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 4.9% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 54% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 98%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (13 analysts) rates it buy, with a mean price target of $383.
2026-07-18Markup$329.83+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with strong ethical credentials. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 54% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 98%. Our forward projection puts the odds of a 10% gain over the next month near 35%. The street (13 analysts) rates it buy, with a mean price target of $383.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
